Cargando…

A homology independent sequence replacement strategy in human cells using a CRISPR nuclease

Precision genomic alterations largely rely on homology directed repair (HDR), but targeting without homology using the non-homologous end-joining (NHEJ) pathway has gained attention as a promising alternative. Previous studies demonstrated precise insertions formed by the ligation of donor DNA into...

Descripción completa

Detalles Bibliográficos
Autores principales: Danner, Eric, Lebedin, Mikhail, de la Rosa, Kathrin, Kühn, Ralf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881171/
https://www.ncbi.nlm.nih.gov/pubmed/33499763
http://dx.doi.org/10.1098/rsob.200283
_version_ 1783650821360058368
author Danner, Eric
Lebedin, Mikhail
de la Rosa, Kathrin
Kühn, Ralf
author_facet Danner, Eric
Lebedin, Mikhail
de la Rosa, Kathrin
Kühn, Ralf
author_sort Danner, Eric
collection PubMed
description Precision genomic alterations largely rely on homology directed repair (HDR), but targeting without homology using the non-homologous end-joining (NHEJ) pathway has gained attention as a promising alternative. Previous studies demonstrated precise insertions formed by the ligation of donor DNA into a targeted genomic double-strand break in both dividing and non-dividing cells. Here, we demonstrate the use of NHEJ repair to replace genomic segments with donor sequences; we name this method ‘Replace’ editing (Rational end-joining protocol delivering a targeted sequence exchange). Using CRISPR/Cas9, we create two genomic breaks and ligate a donor sequence in-between. This exchange of a genomic for a donor sequence uses neither microhomology nor homology arms. We target four loci in cell lines and show successful exchange of exons in 16–54% of human cells. Using linear amplification methods and deep sequencing, we quantify the diversity of outcomes following Replace editing and profile the ligated interfaces. The ability to replace exons or other genomic sequences in cells not efficiently modified by HDR holds promise for both basic research and medicine.
format Online
Article
Text
id pubmed-7881171
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Royal Society
record_format MEDLINE/PubMed
spelling pubmed-78811712021-02-16 A homology independent sequence replacement strategy in human cells using a CRISPR nuclease Danner, Eric Lebedin, Mikhail de la Rosa, Kathrin Kühn, Ralf Open Biol Research Precision genomic alterations largely rely on homology directed repair (HDR), but targeting without homology using the non-homologous end-joining (NHEJ) pathway has gained attention as a promising alternative. Previous studies demonstrated precise insertions formed by the ligation of donor DNA into a targeted genomic double-strand break in both dividing and non-dividing cells. Here, we demonstrate the use of NHEJ repair to replace genomic segments with donor sequences; we name this method ‘Replace’ editing (Rational end-joining protocol delivering a targeted sequence exchange). Using CRISPR/Cas9, we create two genomic breaks and ligate a donor sequence in-between. This exchange of a genomic for a donor sequence uses neither microhomology nor homology arms. We target four loci in cell lines and show successful exchange of exons in 16–54% of human cells. Using linear amplification methods and deep sequencing, we quantify the diversity of outcomes following Replace editing and profile the ligated interfaces. The ability to replace exons or other genomic sequences in cells not efficiently modified by HDR holds promise for both basic research and medicine. The Royal Society 2021-01-27 /pmc/articles/PMC7881171/ /pubmed/33499763 http://dx.doi.org/10.1098/rsob.200283 Text en © 2021 The Authors. http://creativecommons.org/licenses/by/4.0/ http://creativecommons.org/licenses/by/4.0/http://creativecommons.org/licenses/by/4.0/Published by the Royal Society under the terms of the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/, which permits unrestricted use, provided the original author and source are credited.
spellingShingle Research
Danner, Eric
Lebedin, Mikhail
de la Rosa, Kathrin
Kühn, Ralf
A homology independent sequence replacement strategy in human cells using a CRISPR nuclease
title A homology independent sequence replacement strategy in human cells using a CRISPR nuclease
title_full A homology independent sequence replacement strategy in human cells using a CRISPR nuclease
title_fullStr A homology independent sequence replacement strategy in human cells using a CRISPR nuclease
title_full_unstemmed A homology independent sequence replacement strategy in human cells using a CRISPR nuclease
title_short A homology independent sequence replacement strategy in human cells using a CRISPR nuclease
title_sort homology independent sequence replacement strategy in human cells using a crispr nuclease
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881171/
https://www.ncbi.nlm.nih.gov/pubmed/33499763
http://dx.doi.org/10.1098/rsob.200283
work_keys_str_mv AT dannereric ahomologyindependentsequencereplacementstrategyinhumancellsusingacrisprnuclease
AT lebedinmikhail ahomologyindependentsequencereplacementstrategyinhumancellsusingacrisprnuclease
AT delarosakathrin ahomologyindependentsequencereplacementstrategyinhumancellsusingacrisprnuclease
AT kuhnralf ahomologyindependentsequencereplacementstrategyinhumancellsusingacrisprnuclease
AT dannereric homologyindependentsequencereplacementstrategyinhumancellsusingacrisprnuclease
AT lebedinmikhail homologyindependentsequencereplacementstrategyinhumancellsusingacrisprnuclease
AT delarosakathrin homologyindependentsequencereplacementstrategyinhumancellsusingacrisprnuclease
AT kuhnralf homologyindependentsequencereplacementstrategyinhumancellsusingacrisprnuclease